Top Midday Gainers-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Top Midday Gainers

MT Newswires Live03-26

OSR (OSRH) shares surged 116% amid heavy trading after the company's Vaximm subsidiary said Wednesday the final data from a phase 2a trial showed its investigational vaccine VXM01 in combination with avelumab "could offer meaningful clinical benefit" in patients with recurrent glioblastoma, a type of aggressive brain cancer.

Intraday trading volume catapulted to over 75.2 million shares from a daily average of about 1.2 million.

VivoPower International (VVPR) said Wednesday it is in advanced talks with Abu Dhabi-based Energi Holdings on an unsolicited all-cash takeover bid for $120 million. Negotiations between VivoPower's board and Energi are expected to be completed by April 2.

Shares soared 75% as intraday trading volume surged to more than 132 million from a daily average of about 2.7 million.

SurgePays (SURG) said overnight that it expects revenue to exceed $200 million over the next 12 months, compared with sales of $60.9 million reported in 2024.

Shares jumped 61% as intraday trading volume soared to over 63.9 million from a daily average of roughly 295,000.

Price: 3.46, Change: +1.86, Percent Change: +116.44

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

empty

No comments yet

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2522692336?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-27 01:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522692336","market":"fut","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> OSR (OSRH) shares surged 116% amid heavy trading after the company's Vaximm subsidiary said Wednesday the final data from a phase 2a trial showed its investigational vaccine VXM01 in combination with avelumab \"could offer meaningful clinical benefit\" in patients with recurrent glioblastoma, a type of aggressive brain cancer.</p><p>Intraday trading volume catapulted to over 75.2 million shares from a daily average of about 1.2 million.</p><p><a href=\"https://laohu8.com/S/VVPR\">VivoPower</a> International (VVPR) said Wednesday it is in advanced talks with Abu Dhabi-based Energi Holdings on an unsolicited all-cash takeover bid for $120 million. Negotiations between VivoPower's board and Energi are expected to be completed by April 2.</p><p>Shares soared 75% as intraday trading volume surged to more than 132 million from a daily average of about 2.7 million.</p><p>SurgePays (SURG) said overnight that it expects revenue to exceed $200 million over the next 12 months, compared with sales of $60.9 million reported in 2024.</p><p>Shares jumped 61% as intraday trading volume soared to over 63.9 million from a daily average of roughly 295,000.</p><p>Price: 3.46, Change: +1.86, Percent Change: +116.44</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-27 01:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> OSR (OSRH) shares surged 116% amid heavy trading after the company's Vaximm subsidiary said Wednesday the final data from a phase 2a trial showed its investigational vaccine VXM01 in combination with avelumab \"could offer meaningful clinical benefit\" in patients with recurrent glioblastoma, a type of aggressive brain cancer.</p><p>Intraday trading volume catapulted to over 75.2 million shares from a daily average of about 1.2 million.</p><p><a href=\"https://laohu8.com/S/VVPR\">VivoPower</a> International (VVPR) said Wednesday it is in advanced talks with Abu Dhabi-based Energi Holdings on an unsolicited all-cash takeover bid for $120 million. Negotiations between VivoPower's board and Energi are expected to be completed by April 2.</p><p>Shares soared 75% as intraday trading volume surged to more than 132 million from a daily average of about 2.7 million.</p><p>SurgePays (SURG) said overnight that it expects revenue to exceed $200 million over the next 12 months, compared with sales of $60.9 million reported in 2024.</p><p>Shares jumped 61% as intraday trading volume soared to over 63.9 million from a daily average of roughly 295,000.</p><p>Price: 3.46, Change: +1.86, Percent Change: +116.44</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4132","symbol_name":"无线电信业务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2522692336","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522692336","pubTimestamp":1743011975,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"OSR  shares surged 116% amid heavy trading after the company's Vaximm subsidiary said Wednesday the final data from a phase 2a trial showed its investigational vaccine VXM01 in combination with avelumab \"could offer meaningful clinical benefit\" in patients with recurrent glioblastoma, a type of aggressive brain cancer.Intraday trading volume catapulted to over 75.2 million shares from a daily average of about 1.2 million.VivoPower International  said Wednesday it is in advanced talks with Abu Dhabi-based Energi Holdings on an unsolicited all-cash takeover bid for $120 million. Negotiations between VivoPower's board and Energi are expected to be completed by April 2.Shares soared 75% as intraday trading volume surged to more than 132 million from a daily average of about 2.7 million.SurgePays  said overnight that it expects revenue to exceed $200 million over the next 12 months, compared with sales of $60.9 million reported in 2024.Shares jumped 61% as intraday trading volume soared to ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4132":"无线电信业务","BK4133":"新能源发电业者","OSRH":"OSR Holdings","BK4139":"生物科技","VVPR":"VivoPower","SURG":"Surgepays Inc"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSRH":0.9,"SURG":0.9,"VVPR":0.9},"content_text":"OSR (OSRH) shares surged 116% amid heavy trading after the company's Vaximm subsidiary said Wednesday the final data from a phase 2a trial showed its investigational vaccine VXM01 in combination with avelumab \"could offer meaningful clinical benefit\" in patients with recurrent glioblastoma, a type of aggressive brain cancer.Intraday trading volume catapulted to over 75.2 million shares from a daily average of about 1.2 million.VivoPower International (VVPR) said Wednesday it is in advanced talks with Abu Dhabi-based Energi Holdings on an unsolicited all-cash takeover bid for $120 million. Negotiations between VivoPower's board and Energi are expected to be completed by April 2.Shares soared 75% as intraday trading volume surged to more than 132 million from a daily average of about 2.7 million.SurgePays (SURG) said overnight that it expects revenue to exceed $200 million over the next 12 months, compared with sales of $60.9 million reported in 2024.Shares jumped 61% as intraday trading volume soared to over 63.9 million from a daily average of roughly 295,000.Price: 3.46, Change: +1.86, Percent Change: +116.44","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}